ISS and Glass Lewis Recommend Forte Biosciences Stockholders

Both Leading Independent Proxy Advisory Firms Conclude Forte’s Poor Performance and Dilutive, Anti-Stockholder Actions Under Chairman and CEO Dr. Paul Wagner’s Leadership Indicate Boardroom...

Related Keywords

Chris Mcintyre , Paul Wagner , Lawrence Eichenfield , Michael Hacke , Given The Company , Lewis Co , Camac Partners , Corporate Governance Committee , Nasdaq , Institutional Shareholder Services Inc , Capital Management , Forte Biosciences Inc , Company Board , Forte Biosciences , Institutional Shareholder Services , Annual Meeting , Glass Lewis , Founder Chairman , Management Nominees , Dissident Nominees , Gabi Gliksberg , Markets ,